Eight cycles of escalated-dose BEACOPP compared with four cycles of escalated-dose BEACOPP followed by four cycles of baseline-dose BEACOPP with or without radiotherapy in patients with advanced-stage hodgkin"s lymphoma: final analysis of the HD12 trial of the German Hodgkin Study Group.

Peter Borchmann; Heinz Haverkamp; Volker Diehl; Thomas Cerny; Jana Markova; Anthony D Ho; Hans-Theodor Eich; Hans Konrad Mueller-Hermelink; Lothar Kanz; Richard Greil; Andreas Rank; Ursula Paulus; Lenka Smardova; Christoph Huber; Bernd Dörken; Christoph Nerl; Stefan W Krause; Rolf-Peter Mueller; Michael Fuchs; Andreas Engert

doi:10.1200/JCO.2010.33.9549

Eight cycles of escalated-dose BEACOPP compared with four cycles of escalated-dose BEACOPP followed by four cycles of baseline-dose BEACOPP with or without radiotherapy in patients with advanced-stage hodgkin"s lymphoma: final analysis of the HD12 trial of the German Hodgkin Study Group.

Peter Borchmann, Heinz Haverkamp, Volker Diehl, Thomas Cerny, Jana Markova, Anthony D Ho, Hans-Theodor Eich, Hans Konrad Mueller-Hermelink, Lothar Kanz, Richard Greil (Co-author), Andreas Rank, Ursula Paulus, Lenka Smardova, Christoph Huber, Bernd Dörken, Christoph Nerl, Stefan W Krause, Rolf-Peter Mueller, Michael Fuchs, Andreas Engert

Department of Internal Medicine III - Division of Hematology, Medical Oncology, Hemostaseology, Rheumatology, Infectiology and Oncologic Center

Research output: Contribution to journal › Original Article › peer-review

152 Citations (Web of Science)

Original language	English
Pages (from-to)	423-442
Journal	JOURNAL OF CLINICAL ONCOLOGY
Volume	29
Issue number	32
DOIs	https://doi.org/10.1200/JCO.2010.33.9549
Publication status	Published - 2011

Keywords

STUDY-GROUP GHSG
POSITRON-EMISSION-TOMOGRAPHY
ELDERLY-PATIENTS
MOPP/ABV HYBRID
INTERGROUP TRIAL
PROGNOSTIC SCORE
CLINICAL-TRIALS
COPP-ABVD
DISEASE
CHEMOTHERAPY

Access to Document

10.1200/JCO.2010.33.9549

Cite this

Borchmann, P., Haverkamp, H., Diehl, V., Cerny, T., Markova, J., Ho, A. D., Eich, H.-T., Mueller-Hermelink, H. K., Kanz, L., Greil, R., Rank, A., Paulus, U., Smardova, L., Huber, C., Dörken, B., Nerl, C., Krause, S. W., Mueller, R.-P., Fuchs, M., & Engert, A. (2011). Eight cycles of escalated-dose BEACOPP compared with four cycles of escalated-dose BEACOPP followed by four cycles of baseline-dose BEACOPP with or without radiotherapy in patients with advanced-stage hodgkin"s lymphoma: final analysis of the HD12 trial of the German Hodgkin Study Group. JOURNAL OF CLINICAL ONCOLOGY , 29(32), 423-442. https://doi.org/10.1200/JCO.2010.33.9549

Borchmann, Peter ; Haverkamp, Heinz ; Diehl, Volker et al. / Eight cycles of escalated-dose BEACOPP compared with four cycles of escalated-dose BEACOPP followed by four cycles of baseline-dose BEACOPP with or without radiotherapy in patients with advanced-stage hodgkin"s lymphoma: final analysis of the HD12 trial of the German Hodgkin Study Group. In: JOURNAL OF CLINICAL ONCOLOGY 2011 ; Vol. 29, No. 32. pp. 423-442.

@article{377501cb584d4f5c98ced4cc70f0d7c5,

title = "Eight cycles of escalated-dose BEACOPP compared with four cycles of escalated-dose BEACOPP followed by four cycles of baseline-dose BEACOPP with or without radiotherapy in patients with advanced-stage hodgkin{"}s lymphoma: final analysis of the HD12 trial of the German Hodgkin Study Group.",

keywords = "STUDY-GROUP GHSG, POSITRON-EMISSION-TOMOGRAPHY, ELDERLY-PATIENTS, MOPP/ABV HYBRID, INTERGROUP TRIAL, PROGNOSTIC SCORE, CLINICAL-TRIALS, COPP-ABVD, DISEASE, CHEMOTHERAPY",

author = "Peter Borchmann and Heinz Haverkamp and Volker Diehl and Thomas Cerny and Jana Markova and Ho, {Anthony D} and Hans-Theodor Eich and Mueller-Hermelink, {Hans Konrad} and Lothar Kanz and Richard Greil and Andreas Rank and Ursula Paulus and Lenka Smardova and Christoph Huber and Bernd D{\"o}rken and Christoph Nerl and Krause, {Stefan W} and Rolf-Peter Mueller and Michael Fuchs and Andreas Engert",

note = "Richard Greil, University of Salzburg, Salzburg, Austria. ",

year = "2011",

doi = "10.1200/JCO.2010.33.9549",

language = "English",

volume = "29",

pages = "423--442",

journal = "JOURNAL OF CLINICAL ONCOLOGY ",

issn = "0732-183X",

publisher = "Lippincott Williams & Wilkins ",

number = "32",

}

Borchmann, P, Haverkamp, H, Diehl, V, Cerny, T, Markova, J, Ho, AD, Eich, H-T, Mueller-Hermelink, HK, Kanz, L, Greil, R, Rank, A, Paulus, U, Smardova, L, Huber, C, Dörken, B, Nerl, C, Krause, SW, Mueller, R-P, Fuchs, M & Engert, A 2011, 'Eight cycles of escalated-dose BEACOPP compared with four cycles of escalated-dose BEACOPP followed by four cycles of baseline-dose BEACOPP with or without radiotherapy in patients with advanced-stage hodgkin"s lymphoma: final analysis of the HD12 trial of the German Hodgkin Study Group.', JOURNAL OF CLINICAL ONCOLOGY , vol. 29, no. 32, pp. 423-442. https://doi.org/10.1200/JCO.2010.33.9549

Eight cycles of escalated-dose BEACOPP compared with four cycles of escalated-dose BEACOPP followed by four cycles of baseline-dose BEACOPP with or without radiotherapy in patients with advanced-stage hodgkin"s lymphoma: final analysis of the HD12 trial of the German Hodgkin Study Group. / Borchmann, Peter; Haverkamp, Heinz; Diehl, Volker et al.
In: JOURNAL OF CLINICAL ONCOLOGY , Vol. 29, No. 32, 2011, p. 423-442.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - Eight cycles of escalated-dose BEACOPP compared with four cycles of escalated-dose BEACOPP followed by four cycles of baseline-dose BEACOPP with or without radiotherapy in patients with advanced-stage hodgkin"s lymphoma: final analysis of the HD12 trial of the German Hodgkin Study Group.

AU - Borchmann, Peter

AU - Haverkamp, Heinz

AU - Diehl, Volker

AU - Cerny, Thomas

AU - Markova, Jana

AU - Ho, Anthony D

AU - Eich, Hans-Theodor

AU - Mueller-Hermelink, Hans Konrad

AU - Kanz, Lothar

AU - Greil, Richard

AU - Rank, Andreas

AU - Paulus, Ursula

AU - Smardova, Lenka

AU - Huber, Christoph

AU - Dörken, Bernd

AU - Nerl, Christoph

AU - Krause, Stefan W

AU - Mueller, Rolf-Peter

AU - Fuchs, Michael

AU - Engert, Andreas

N1 - Richard Greil, University of Salzburg, Salzburg, Austria.

PY - 2011

Y1 - 2011

KW - STUDY-GROUP GHSG

KW - POSITRON-EMISSION-TOMOGRAPHY

KW - ELDERLY-PATIENTS

KW - MOPP/ABV HYBRID

KW - INTERGROUP TRIAL

KW - PROGNOSTIC SCORE

KW - CLINICAL-TRIALS

KW - COPP-ABVD

KW - DISEASE

KW - CHEMOTHERAPY

U2 - 10.1200/JCO.2010.33.9549

DO - 10.1200/JCO.2010.33.9549

M3 - Original Article

C2 - 21990399

SN - 0732-183X

VL - 29

SP - 423

EP - 442

JO - JOURNAL OF CLINICAL ONCOLOGY

JF - JOURNAL OF CLINICAL ONCOLOGY

IS - 32

ER -

Borchmann P, Haverkamp H, Diehl V, Cerny T, Markova J, Ho AD et al. Eight cycles of escalated-dose BEACOPP compared with four cycles of escalated-dose BEACOPP followed by four cycles of baseline-dose BEACOPP with or without radiotherapy in patients with advanced-stage hodgkin"s lymphoma: final analysis of the HD12 trial of the German Hodgkin Study Group. JOURNAL OF CLINICAL ONCOLOGY . 2011;29(32):423-442. doi: 10.1200/JCO.2010.33.9549